main-logo

ICD-10 Code C92.62 | Acute myeloid leukemia with 11q23-abnormality in relapse Symptoms, Diagnosis, Billing

Acute myeloid leukemia with 11q23-abnormality in relapse is a hematological malignancy characterized by the proliferation of myeloid cells with a specific chromosomal abnormality. This condition is clinically significant due to its aggressive nature and poor prognosis. Accurate coding with ICD-10 Code C92.62 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.

What is ICD-10 Code C92.62 for Acute myeloid leukemia with 11q23-abnormality in relapse?

ICD-10 Code C92.62 represents Acute myeloid leukemia with 11q23-abnormality in relapse, indicating a recurrence of this specific type of leukemia characterized by genetic abnormalities. This code should be used in clinical documentation and billing when a patient presents with relapsed symptoms following initial treatment, ensuring accurate representation of the patient's condition for healthcare providers and payers.

ICD-10 Code C92.62 – Clinical Definition and Explanation of Acute myeloid leukemia with 11q23-abnormality in relapse

Acute myeloid leukemia with 11q23-abnormality in relapse is a severe form of leukemia that arises from the malignant transformation of myeloid progenitor cells, often associated with poor outcomes. The 11q23 chromosomal abnormality is linked to specific genetic mutations that contribute to the disease's aggressiveness. Prompt medical attention is crucial due to the rapid progression of the disease.

Key Clinical Features:

  • Presence of myeloblasts in peripheral blood and bone marrow.
  • Symptoms may include fatigue, fever, and bleeding tendencies.
  • Associated with specific genetic mutations, particularly in the MLL gene.
  • Higher incidence in adults, with a poor prognosis compared to other leukemias.

ICD-10 Code C92.62 for Acute myeloid leukemia with 11q23-abnormality in relapse – SOAP Notes & Clinical Use

ICD-10 Code C92.62 is utilized in SOAP notes to document the patient's symptoms, assessment, and treatment plan for Acute myeloid leukemia with 11q23-abnormality in relapse. This code is relevant in both acute and chronic care settings, facilitating clear communication among healthcare providers and ensuring appropriate management of the patient's condition.

What Does ICD-10 Code C92.62 for Acute myeloid leukemia with 11q23-abnormality in relapse Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C92.62 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Acute myeloid leukemia with 11q23-abnormality in relapse. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C92.62 – Acute myeloid leukemia with 11q23-abnormality in relapse

The management of Acute myeloid leukemia with 11q23-abnormality in relapse requires urgent intervention, often necessitating hospitalization for intensive treatment.

Antibiotic Therapy:

  • Ciprofloxacin: First-line for prophylaxis, typically for 7-14 days.
  • Piperacillin-tazobactam: Alternative for febrile neutropenia, duration based on clinical response.
  • Vancomycin: Consider for suspected infections, duration based on culture results.

Supportive Care:

  • Transfusion support for anemia and thrombocytopenia.
  • Growth factors (e.g., G-CSF) to stimulate bone marrow recovery.
  • Pain management and palliative care as needed.

Infection Control:

  • Strict hand hygiene protocols to prevent infection.
  • Isolation precautions for neutropenic patients.
  • Monitoring for signs of infection during treatment.

How to Document Symptoms of Acute myeloid leukemia with 11q23-abnormality in relapse (ICD-10 C92.62) in SOAP Notes

Subjective:

  • Patient reports increased fatigue and weakness.
  • History of recurrent infections and unexplained bruising.
  • Complaints of fever and night sweats.
  • Previous treatment for acute myeloid leukemia with remission noted.

Objective:

  • CBC shows leukocytosis with myeloblasts present.
  • Bone marrow biopsy confirms 11q23-abnormality.
  • Vital signs: Temperature 101°F, heart rate 110 bpm.
  • Physical exam reveals pallor and petechiae.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Acute myeloid leukemia with 11q23-abnormality in relapse (ICD-10 Code C92.62)

Assessment:

  • Diagnosis: Acute myeloid leukemia with 11q23-abnormality in relapse, severe.
  • ICD-10 Code: C92.62.
  • Triggers: Previous treatment failure and genetic predisposition.
  • Complications: Risk of infection and bleeding.

Plan:

  • Initiate chemotherapy regimen as per protocol.
  • Consider stem cell transplant evaluation.
  • Schedule regular CBC monitoring and supportive care.
  • Educate patient on signs of infection and when to seek care.

Treatment & Plan Section for ICD-10 Code C92.62 – Acute myeloid leukemia with 11q23-abnormality in relapse

  • First-line treatment includes intensive chemotherapy regimens.
  • Consideration for targeted therapy based on genetic profiling.
  • Regular monitoring of blood counts and organ function.
  • Patient education on managing side effects and recognizing complications.

Using ICD-10 Code C92.62 for Acute myeloid leukemia with 11q23-abnormality in relapse in Billing & SOAP Note Compliance

  • Select appropriate ICD-10 code based on clinical documentation.
  • Ensure subjective and objective findings are clearly documented.
  • Align treatment plans with clinical guidelines for justified billing.
  • Include relevant CPT codes that correspond to the services provided.

ICD-10 Code C92.62 in Medical Billing and Insurance for Acute myeloid leukemia with 11q23-abnormality in relapse

ICD-10 Code C92.62 is critical in medical billing, particularly in hospital, emergency room, or infectious disease care settings.

Billing Notes:

  • Document all relevant clinical findings to support the use of this code.
  • Use in conjunction with appropriate CPT codes for treatment services.
  • Ensure that the patient's history of relapse is clearly noted in the medical record.
  • Review payer guidelines for specific documentation requirements.

Common CPT Pairings:

CPT CodeDescription
85027Complete blood count with differential.
38221Bone marrow aspiration and/or biopsy.
96413Chemotherapy administration, intravenous, push.
99223Initial hospital care, typically 70 minutes.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C92.62 for Acute myeloid leukemia with 11q23-abnormality in relapse

What are the common symptoms of Acute myeloid leukemia with 11q23-abnormality in relapse?

Common symptoms include fatigue, fever, easy bruising or bleeding, and recurrent infections. Patients may also experience weight loss and night sweats.

How is Acute myeloid leukemia with 11q23-abnormality in relapse treated?

Treatment typically involves intensive chemotherapy, and in some cases, stem cell transplantation may be considered. Supportive care is also crucial to manage symptoms and complications.

When should ICD-10 Code C92.62 be used?

This code should be used when documenting a relapse of Acute myeloid leukemia with 11q23-abnormality, particularly after a previous treatment regimen.

What is the prognosis for patients with this condition?

The prognosis for Acute myeloid leukemia with 11q23-abnormality in relapse is generally poor, with a high risk of complications and a lower likelihood of long-term remission compared to other forms of leukemia.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved